Literature DB >> 33493733

Prevalence and onset of anxiety and related disorders throughout pregnancy: A prospective study in an Australian sample.

Kirupamani Viswasam1, David Berle2, Denise Milicevic3, Vladan Starcevic4.   

Abstract

The aims of this study were to investigate the prevalence of anxiety and related disorders (e.g., obsessive-compulsive disorder [OCD]) and major depressive disorder (MDD) at any time during pregnancy and during each pregnancy trimester and ascertain the proportions of women with an onset of these disorders during pregnancy. Several questionnaires and the Mini International Neuropsychiatric Interview were administered to 200 women at each pregnancy trimester. Complete data were obtained from 148 participants. The most prevalent anxiety disorder at any time during pregnancy was panic disorder (PD), followed by generalised anxiety disorder (GAD) and OCD. Unlike all the other disorders, the prevalence rates of OCD increased steadily from the first to the third trimester. Approximately one half of women with OCD and about one third of women with PD, GAD and MDD at any time during pregnancy had an onset of these disorders during pregnancy. Pregnancy may be a risk factor for an onset of OCD and to a lesser extent, for an onset of PD, GAD and MDD. Absence of remission of OCD during pregnancy despite treatment may suggest treatment resistance of OCD at this time. These findings have implications for recognition, prevention and treatment of anxiety disorders during pregnancy.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety disorders; Obsessive-compulsive disorder; Panic disorder; Pregnancy; Prevalence

Mesh:

Year:  2021        PMID: 33493733     DOI: 10.1016/j.psychres.2021.113721

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  Giving sleep position advice in pregnancy: Will we make women anxious?

Authors:  Jane Warland; Sarah Footner; Georgie Beaufoy; Jade Stocker; Alex Agostini; Jillian Dorrian
Journal:  Aust N Z J Obstet Gynaecol       Date:  2022-03-20       Impact factor: 1.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.